You are on page 1of 22

MALARIA IN

PREGNANCY
Margaret Diana
BACKGROUND
 Greatest challenge today is Resistance to Drugs
CAUSES OF MALARIA
CLINICAL FEATURES

Symptomps Signs
fever jaundice
headache prespiration
muscle pain pallor
nausea splenomegali
vommiting resp.distress
diarrhea muscle pain
cough
malaise
SEVERE CLINICAL FEATURES
Severe haemolytic
Cerebral malaria/
Metabolic acidosis anaemia/black
coma
water fever

Pulmonary
Acute renal oedema / adult
Hypoglycaemia
failure respiratory
distress syndrome

DIC hypotension convulsions


PROBLEMS
Frequent

Atipic

Severe

Fatal

Selective theraphy

others
MATERNAL EFFECTS OF
MALARIA
Anaemia in pregnancy

More common and severe young primigravidae

Starts in mid trimester (16 – 24th w)

Haemolysis and sequestration of infected RBCs into the RES.

Haemolysis of non-parasitized RBCs

TNF : Bone marrow suppression

Loss of appetite
FETAL EFFECTS OF MALARIA
• Induction of uterine contractions
Pyrexia • Abortions, preterm labour.
• IUFD and fetal distress.

• placental parasitization -> IUGR, LBW,


Placental IUFD.
• Placental Reaction : clogging of the
Parasitization intervillous spaces with macrophages

• Very rare
Congenital • Fever, hepatosplenomegaly,anaemia,
Malaria icteric
• d/ blood smear
IMMUNITY IN ENDEMIC AREAS
• Low mortality rate
• Mostly asimptomatic
High
immunity • Parasitemia rarely occured

• Squesteration : LBW, Ab, IUFD, preterm,


placenta
• Placental malaria

• Usually negative
blood
• Parasitemia : tm 2 & 3

• Higher parasitemia
1st & 2nd
pregnancy
PROTECTIVE MECHANISMS OF THE FETUS IN
UTERO

Immune mother transmit passive immunity


(antimalarial IgG) to the fetus.

The few parasites that succeed are destroyed by


the antimalarial IgG

The placenta greatly limits the number of


parasites gaining access into the fetal circulation.

Falciparum parasites do not grow well in fetal RBC


containing Hb F.
IMMUNITY IN NON ENDEMIC
AREAS
Higher
Higher risk mortality
rate

Abortion Low birth


>60% weight

symptomatic
DIAGNOSIS
Importance
• reduce unnecessary use of antimalarials.
• High specificity
Methods
• Clinical diagnosis - low specificity
• Detection of parasites in the blood.
Parasitological diagnosis
• Microscope
• Rapid diagnostic tests (RDTs)
ANTIMALARIALS IN PREGNANCY
Quinine, chloroquine, proguanil,
pyrimethamine and sulfadoxine–
pyrimethamine.
• quinine : the most effective & can be used in all
trimesters of pregnancy including the first trimester.

Amodiaquine, chlorproguanil- dapsone,


halofantrine, lumefantrine and piperaquine
• Have not been evaluated sufficiently to permit
positive recommendations.
Sulfadoxine–pyrimethamine

• safe
• ineffective in many areas -> resistance

Primaquine and tetracyclines

• Should not be used in pregnancy

Despite these many uncertainties, effective


treatment must not be delayed in pregnant
women.
THERAPHY : NON FALCIPARUM SP

Cloroquin 25mg/kg
Amodiaquin :
effective but few datas
agranulositosis

Primakuin : RBC haemolisis


FALCIPARUM
Starts theraphy imidietly - asimtomatic

Chloroquin : not efective

Sulfadoxin-pyrimetamin

Kuinin – clyndamicin : highly effective for


multidrug ressistance -hipoglychaemia

Artesunate 4 mg/kg : TM 2 & 3


SEVERE MALARIA

• No hipoglychaemia
artesunate • 2-4mg/kg

• Quinine 10 mg/kg
quinine
THANK YOU

You might also like